The identification of novel 5′-amino gemcitabine analogs as potent RRM1 inhibitors-Reference-Cited by-同舟云学术

The identification of novel 5′-amino gemcitabine analogs as potent RRM1 inhibitors

Published:2014-04 Issue:7 Volume:22 Page:2303-2310
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Labroli Marc A.,Dwyer Michael P.,Shen Ruichao,Popovici-Muller Janeta,Pu Qinglin,Wyss Daniel,McCoy Mark,Barrett Dianah,Davis Nicole,Seghezzi Wolfgang,Shanahan Frances,Taricani Lorena,Beaumont Maribel,Malinao Maria-Christina,Parry David,Guzi Timothy J.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference44 articles.

1. Ribonucleotide Reductases

2. Reduction of Ribonucleotides

3. Survival of DNA Damage in Yeast Directly Depends on Increased dNTP Levels Allowed by Relaxed Feedback Inhibition of Ribonucleotide Reductase

4. INTERACTIONS BETWEEN DEOXYRIBONUCLEOTIDE AND DNA SYNTHESIS

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is it still worth renewing nucleoside anticancer drugs nowadays?;European Journal of Medicinal Chemistry;2024-01

2. Design, synthesis and antitumor activity study of a gemcitabine prodrug conjugated with a HDAC6 inhibitor;Bioorganic & Medicinal Chemistry Letters;2022-09

3. Poly(anhydride-ester) gemcitabine: Synthesis and particle engineering of a high payload hydrolysable polymeric drug for cancer therapy;Journal of Controlled Release;2021-02

4. Small Molecular Gemcitabine Prodrugs for Cancer Therapy;Current Medicinal Chemistry;2020-10-08

5. Ribonucleotide Reductases: Structure, Chemistry, and Metabolism Suggest New Therapeutic Targets;Annual Review of Biochemistry;2020-06-20